NCT02712411

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

A Randomized, Open-Label, Crossover, Single-Dose Study to Compare Pharmacokinetic Properties and Safety After Administration of HCP1303 Capsule and Co-administration of HGP1201 Tablet, HIP1402 Capsule in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: Male
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

To investigate the pharmacokinetic properties and safety after administration of HCP1303 and co-administration of HGP1201, HIP1402 in healthy male volunteers

Detailed description

The purpose of this study is to investigate the pharmacokinetic properties and safety after administration of HCP1303 and co-administration of HGP1201, HIP1402 in healthy male volunteers

Conditions

• Erectile Dysfunction
• Prostatic Hyperplasia

Interventions

Type	Name	Description
DRUG	HCP1303
DRUG	HGP1201
DRUG	HIP1402

Timeline

• Start date: 2015-07-01
• Primary completion: 2015-08-01
• Completion: 2015-09-01
• First posted: 2016-03-18
• Last updated: 2016-03-18

Locations

1 site across 1 country: South Korea